RI H7923

Removes specific morphine milligram equivalent (MME) dosage limits for opioid prescriptions, replacing them with requirements to prescribe "the lowest effective dosage" for the "expected duration of pain"

Limits initial opioid prescriptions for acute pain to a maximum 7-day supply for adults, and no more than 20 doses for minors

Adds new definitions for "acute pain" (less than 30 days), "chronic pain" (90+ days), "chronic intractable pain," and "opioid therapy" to the Uniform Controlled Substances Act

Requires practitioners to check the prescription drug monitoring program and verify methadone/buprenorphine use before initiating or refilling opioid prescriptions, with reviews every 3 months for patients on continuous opioid therapy

Repeals Chapter 5-37.4 (Intractable Pain Treatment Act) and consolidates its provisions into a new section (21-28-3.20.1) that allows practitioners to prescribe controlled substances for cancer, palliative care, and chronic intractable pain without regard to CDC prescribing guidelines